ACNE BOOT CAMP TOPICAL THERAPY BASICS
|
|
- Ethan Burns
- 6 years ago
- Views:
Transcription
1 ACNE BOOT CAMP TOPICAL THERAPY BASICS Lawrence J Green, MD Associate Clinical Professor of Dermatology George Washington University School of Medicine Washington DC
2 Relevant Disclosures Investigator -Allergan, Dermira, Foamix, Valeant Speaker -Valeant Consultant -Allergan, Dermira, Valeant
3 Overview Acne is a common condition, but can be confused with other facial skin conditions Proper diagnosis is key to successful acne treatment Recognizing unique acne signs can prevent misdiagnosis Gollnick. Drugs. 2003:63;
4 Acne Pathophysiology Acne is caused by 4 interrelated processes affecting the pilosebaceous unit 1,2 Altered follicular hyperkeratinization Sebaceous gland hyperactivity Propionibacterium acnes (P acnes) proliferation Inflammation/immune hypersensitivity to P acnes References: 1. Thiboutot. J Am Acad Dermatol. 2002;47: Berson and Shalita. J Am Acad Dermatol. 1995;32:S31-S41.
5 Comedonal Acne
6
7 Mild Inflammatory Acne
8
9 Acne Treatment Goals Reduce/eliminate comedones/inflammatory lesions 1 Reduce P acnes Reduce dilated pores Reduce inflammatory response Prevent sequelae 2 Minimize psychological effects Minimize scarring References: 1. Leyden. J Eur Acad Dermatol Venereol. 2001;15(suppl 3): Layton. Am J Clin Dermatol. 2001;2;
10 Mechanisms of Topical Acne Therapy Therapy Comedogenesis P acnes Inflammation BPO Retinoids Antibiotics References: 1. Leyden. N Engl J Med. 1997;336: Bershad. Mt Sinai J Med. 2001;68:
11 Benzoyl Peroxide (BPO) Mechanism 1 P acnes (bactericidal) Comedolysis 2 Preparations 1 OTC/Rx (2.5% 10%) Safety 1 Irritation, dry skin Bleaching of fabric Rare allergic contact dermatitis References: 1. Bershad. Mt Sinai J Med. 2001;68: Oh and Myung. J Dermatol. 1996;23:
12 Topical Retinoids Mechanisms 1 Normalizes follicular keratinization Inflammation Clinical utility 2 Treatment of comedonal and inflammatory lesions Available in 3 forms: tretinoin, adapalene, tazarotene Safety 1,2 Skin irritation Photosensitivity Acne flare prior to perceived improvement References: 1. Bershad. Mt Sinai J Med. 2001;68: Layton. Am J Clin Dermatol. 2001;2:
13 Topical Antibiotics/Anti-Inflammatory (besides BPO) Clindamycin Erythromycin Dapsone 5% and 7.5% Azaleic acid Minocycline (coming soon) Sebum inhibitors (coming soon) Mechanisms Antibacterial Anti-inflammatory Risk of resistant strains of P acnes with antibiotics alone References: 1. Bershad. Mt Sinai J Med. 2001;68: Layton. Am J Clin Dermatol. 2001;2: Toyoda et al. Dermatology. 1998;196:
14 /wepdwu 64912ABF ACZONE (dapsone) 7.5% w/w Topical gel: A Product for the Topical Treatment of Acne Once-daily dosing 1 Proven efficacy and tolerability 1,2 Studied in large pivotal trials used for a topical acne drug acne patients studied 2 100% had moderate acne 1, 3 Features a pump design 1 1. ACZONE Gel 7.5% w/w topical gel Australian Approved Product Information. 2. Thiboutot DM et al. J Clin Aesthet Dermatol 2016; 9(10): Eichenfield MD et al. J Drugs in Dermatol 2016; 15(8)
15 Inflammatory Lesion Count Reduction At Week 12 1,* Mean Percentage Reduction From Baseline 0% -10% -20% -30% -40% -50% -60% -70% (29.8) ACZONE 7.5% w/w Topical gel (21.1) Vehicle ACZONE (dapsone) 7.5% w/w gel (n = 2162) P<0.01 P<0.001 Vehicle (n = 2178) Week P<0.001 Adapted from Thiboutot % (-13.9) -54.6% (-15.8) P <.001 Study design: Pooled analysis of 4,340 patients in 2 identical, 12-week, multicenter, randomized, double-blind, vehicle-controlled, parallel-group studies. Aczone Vehicle 1. Thiboutot DM et al. J Clin Aesthet Dermatol 2016; 9(10):
16 Comedonal (Noninflammatory) Lesion Count Reduction at Week 12 1, * Mean Percentage Reduction From Baseline 0% -10% -20% -30% -40% -50% -60% (46.8) ACZONE 7.5% w/w Topical gel (47.6) Vehicle Aczone ACZONE (dapsone) 7.5% w/w gel (n = 2162) Vehicle (n = 2178) P< % (-18) -45.1% (-20.7) P < % Week Adapted from Thiboutot 2016 Study design: Pooled analysis of 4,340 patients in 2 identical, 12-week, multicenter, randomized, double-blind, vehicle-controlled, parallel-group studies. 1. Thiboutot DM et al. J Clin Aesthet Dermatol 2016; 9(10):
17 Local Dermal Tolerability Assessments 1 Pooled Tolerability: Erythema Scaling Dryness Stinging/Burning (PATIENT ASESSED) (n=2175) (n=2161) Mean Severity Score 0 = none 1 = mild 2 = moderate 3 = severe 1. Thiboutot DM et al. J Clin Aesthet Dermatol 2016; 9(10):
18 Use of Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel Treatment 18
19 Results Mean % decrease in inflammatory lesion counts Decrease Compared to Baseline 0.0% -20.0% -40.0% -60.0% -39.8% -54.7% -80.0% -79.4% -80.5% -78.0% -77.8% % Week 4 Week 8 Week 12 Week 16 Week 20 Week 24 All results are statistically significant (p<.0001) 19
20 Combination Topical Antibiotic/BPO Products Topical antibiotic/bpo combinations Reduce P acnes proliferation and associated inflammation Have mild direct and indirect comedolytic activity Provide improved efficacy and reduced risk for resistance Appear to be most beneficial in patients with mild-to-moderate inflammatory acne
21 Combination Therapy Is Standard of Care
22 Adapalene 0.1%/BPO 2.5% Gel: Long Term Study Efficacy: Lesion Count Reduction (Per protocol population [N=327]) Median Change in Lesion Counts (%) n= n=397 (88%) 3+ mos n=366 (81%) 6+mos n=334 (73.9%) 9+mos D. Pariser, P. Westmoreland, A. Morris, et al. Long-Term Safety and Efficacy of a Unique Fixed-Dose Combination Gel of Adapalene 0.1% and Benzoyl Peroxide 2.5% for the Treatment of Acne Vulgaris. J Drugs Dermatol. 2007;6(9): Total 70.8% Inflammatory 76% Non-inflammatory n=327 (72.3%) 12 mos 70%
23 Inflammatory Lesion Reduction With Topical Combination Product 0-10 Mean Change From Baseline (%) % -34% -19% Clindamycin 1%-BPO 5% gel BPO 5% gel % * Clindamycin 1% gel Vehicle * P < 0.05 versus other treatments. Duac Topical Gel [package insert]. Stiefel Laboratories, Inc; 2004.
24 Reduction of P acnes: Topical Combinations Versus Antibiotics Alone 0 Erythromycin Clindamycin + BPO + BPO BPO Clindamycin Erythromycin Azelaic Acid Reduction in P acnes (Log cm 2 ) Adapted from Leyden. Semin Cutan Med Surg. 2001;20:
25 BPO 3.75 / CP 1.2 Long Term Lesion Count Reductions Kircik LH. J Drugs Dermatol Jun 1;16(6):
26 Greater Efficacy When Combined With a Retinoid Patients (%) % 90% 56% 73% 24% 29% 0 50% Global Improvement 75% Global Improvement 90% Global Improvement Tazarotene Tazarotene + Clindamycin/benzoyl peroxide 90% of patients achieved 50% global improvement with Duac Topical Gel (clindamycin 1%, benzoyl peroxide 5%) + retinoid (tazarotene), more than with tazarotene alone in 12-week study Reference: Tanghetti et al. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, La.
27 Significant Clearing of Moderate-to-Severe Acne Median Change in Papule and Pustule Count (%) % -30% Week % -52% Tazarotene 0.1% cream Tazarotene 0.1% cream + Duac Topical Gel (clindamycin 1%, benzoyl peroxide 5%) -52% * -63% * P 0.01 versus tazarotene alone. Significant reduction with combination regimen from baseline inflammatory lesion count 25 Reference: Tanghetti et al. Poster presented at: 63rd Annual Meeting of the American Academy of Dermatology; February 18-22, 2005; New Orleans, La. 27
28 The Effect of 24 Weeks of Adapalene 0.3% and Benzoyl Peroxide 2.5% Gel Versus Vehicle Gel on the Risk of Formation of Atrophic Acne Scars in Moderate to Severe Acne Subjects RESULTS Clinical Study RD.03.SPR , Galderma R&D.
29 A/BPO 0.3%/2.5% vs Vehicle and Scar Formation Risk in Moderate to Severe Acne: Total Atrophic Acne Scar Count at Week 24 Atrophic Acne Scar Count at Week 24 Atrophic Acne Scars (Mean Number) * * * 12.1 A/BPO 0.3%/2.5% Epiduo Forte Vehicle * P-value <.0001 * 2 0 Total scar - ITT/LOCF Total scar - PP Scar 2-4mm - ITT/LOCF Scar >4mm - ITT/LOCF After 24 weeks: There was a mean of about 4 fewer acne scars (total scars) on the A/BPO 0.3%/2.5% Gel treated half-face Fewer scars of both scar sizes assessed were observed in the A/BPO 0.3%/2.5% Gel treated half-face Clinical Study RD.03.SPR , Galderma R&D.
30 A/BPO 0.3%/2.5% vs Vehicle and Scar Formation Risk in Moderate to Severe Acne: Total Atrophic Acne Scar Count by Visit Atrophic Acne Scars (Mean) Total Atrophic Acne Scar Count by Visit (ITT/LOCF) 11.3 * * * Epiduo Forte Vehicle * P-value < * 9.5 * * * 4 Week A/BPO 0.3%/2.5% was significantly superior to its vehicle at all study visits and as early as week 1 Mean scar counts decreased over time with A/BPO 0.3%/2.5% Clinical Study RD.03.SPR , Galderma R&D.
31 A/BPO 0.3%/2.5% vs Vehicle and Scar Formation Risk in Moderate to Severe Acne: Percent Change From Baseline - Total Atrophic Scar Count Percent Change From Baseline: Total Atrophic Acne Scar Count by Visit (ITT/LOCF) 30 Percent Change (Mean) * P-value < * * -4.5 * * * -8.7 * * Week A/BPO 0.3%/2.5% was significantly superior to vehicle at all study visits and as early as week 1 The mean number of scars decreased over time with A/BPO 0.3%/2.5% The mean number of scars increased over time with the vehicle The difference in the mean percent change in scars (A/BPO 0.3%/2.5% vs vehicle) after 24 weeks was 29.9% Clinical Study RD.03.SPR , Galderma R&D.
32 Take away for your practice New topical drugs are coming over the next few years For now, combination therapy is standard of care continued improvements over time in the real world Non-BPO combos exist Combine with BPO cleansers to prevent antibiotic resistance
33 THANK YOU! Larry Green
ACNE UPDATE 2017 FACULTY DISCLOSURE ACNE UPDATE
ACNE UPDATE 2017 PATRICIA TREADWELL, M.D. PROFESSOR OF PEDIATRICS AND DERMATOLOGY IU SCHOOL OF MEDICINE FACULTY DISCLOSURE I have no relevant financial relationships with the manufacturer(s) of any commercial
More informationAcne is one of the most common skin diseases. It usually occurs during adolescence, but can
DOI: 10.5124/jkma.2010.53.7.623 pissn: 1975-8456 eissn: 2093-5951 http://jkma.org Pharmacotherapeutics Pharmacologic Treatment of Acne Dae Hun Suh, MD Department of Dermatology, Seoul National University
More informationAcne vulgaris is a disease of the pilosebaceous unit (i.e., the sebaceous glands and adjacent hair follicle).
Dr. Ghassan Salah Acne is a common, chronic inflammatory disorder of the pilosebaceous unit in which a microcomedo develops as the initial condition. The most common form of acne is acne vulgaris. Other
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 18 January 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 January 2012 EPIDUO, gel Tube of 30 g (CIP code: 383 814-6) Tube of 60 g (CIP code: 383 816-9) Applicant: GALDERMA
More informationACNE. Jason M Cheyney, MPAS, PA-C Dermatologic Surgery Specialists Macon, Ga 31211
ACNE Jason M Cheyney, MPAS, PA-C Dermatologic Surgery Specialists Macon, Ga 31211 Pathogenesis of Acne Causative Factors Therapy On the horizon Approximately 45 million Americans have acne It is often
More informationInternational Journal of Pharma and Bio Sciences
Research Article Pharmacology International Journal of Pharma and Bio Sciences ISSN 0975-6299 COMPARISION OF CLINICAL EFFICACY OF TOPICAL CLINDAMYCIN WITH ADAPALENE AND ADAPALENE ALONE IN TREATMENT OF
More informationManagement of Truncal Acne Vulgaris: Current Perspectives on Treatment
DRUG THERAPY TOPICS Management of Truncal Acne Vulgaris: Current Perspectives on Treatment James Q. Del Rosso, DO Acne vulgaris is one of the most common disorders encountered by dermatologists in the
More informationBrigitte Dréno 1 Robert Bissonnette. Benjamin Barankin 4 Charles Lynde
Am J Clin Dermatol (2018) 19:275 286 https://doi.org/10.1007/s40257-018-0352-y ORIGINAL RESEARCH ARTICLE Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in
More informationJerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada. Pathogenesis & management of acne scarring
Jerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada Pathogenesis & management of acne scarring Disclosures Relationships with commercial interests: Abbott Laboratories A(Grants/Research
More informationPharmacologic Therapy for Acne
CE/CME Pharmacologic Therapy for Acne A Primer for Primary Care Many of the 50 million persons affected by acne in the United States present to primary care. Acne severity guides treatment choices, which
More informationAcne Vulgaris. This non promotional presentation has been sponsored and developed by Galderma for UK healthcare professionals only.
Acne Vulgaris [Speaker Name] [Speaker Title] This non promotional presentation has been sponsored and developed by OTH18-07-0203 DOP: August 2018 Learning Objectives Explain the pathophysiology of acne
More informationReview Acne Pathogenesis Clinical Evaluation Treatment Guidelines
Tiffany Herd, MD Pediatric Dermatology Fellow Baylor College of Medicine/Texas Children's Hospital Review Acne Pathogenesis Clinical Evaluation Treatment Guidelines Psychosocial Impact of Acne Acne is
More informationJEADV SUPPLEMENT ARTICLE
DOI: 10.1111/jdv.13194 JEADV SUPPLEMENT ARTICLE Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication
More informationACNE VULGARIS: DIAGNOSIS AND TREATMENT
ACNE VULGARIS: DIAGNOSIS AND TREATMENT Federal Bureau of Prisons Clinical Guidance DECEMBER 2017 Clinical guidance is made available to the public for informational purposes only. The Federal Bureau of
More informationTopical Retinoids Prior Authorization Criteria Program Summary
Topical Retinoids Prior Authorization Criteria Program Summary OBJECTIVE The intent of the Retinoids Prior Authorization (PA) criteria is to discourage use of the listed target agents for the treatment
More informationThe surest route to success in treating acne
Applied Evidence R ESEARCH F INDINGS T HAT A RE C HANGING C LINICAL P RACTICE Management of acne David C. Liao, MD, Naval Hospital Camp Pendleton; Irvine, California Abstract Precise classification methods
More informationClinical Medicine Insights: Dermatology. Real Word Acne Therapy in Primary Care. Neel Malhotra 1, Timothy E. Pyra 2 and Jaggi Rao 2
Clinical Medicine Insights: Dermatology Review Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Real Word Acne Therapy in Primary Care Neel Malhotra 1, Timothy
More informationNew Formulations and Research Support Individualized, Adherence-Promoting Topical Acne Regimens
New Formulations and Research Support Individualized, Adherence-Promoting Topical Acne Regimens Good tolerability, convenience, and simplicity all positively influence adherence with topical acne therapy.
More informationExpert Opine: A Report on Acne Management in India
Review Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/138 Expert Opine: A Report on Acne Management in India Dhiraj Dhoot 1, Aniket Samant 2 1 Manager, Medical Services, Glenmark
More informationTo order reprints or e-prints of JDD articles please contact JDD
June 2017 534 VOLUME 16 ISSUE 6 Copyright 2017 ORIGINAL ARTICLE Journal of Drugs in Dermatology The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris Lauren K. Hoffman
More informationDD PROOFS. Acne vulgaris is a multifactorial skin disorder affecting
June 2014 611 Copyright 2014 ORIGINAL ARTICLES SPECIAL TOPIC Rapid Treatment of Mild Acne With a Novel Skin Care System Containing 1% Salicylic Acid, 10% Buffered Glycolic Acid and Botanical Ingredients
More informationTherapy Eur J Dermatol 2014; 24(2): 201-9
Therapy Eur J Dermatol 214; 24(2): 21-9 Brigitte DRÉNO 1 Vincenzo BETTOLI 2 Falk OCHSENDORF 3 Alison M. LAYTON 4 Montserrat PEREZ 5 Rada DAKOVIC 6 Harald GOLLNICK 7 1 Dept of Dermato-Cancerology, University
More informationLecture 4 & 6 Acne Vulgaris Miller & Klassen
Lecture 4 & 6 Acne Vulgaris Miller & Klassen Acne Vulgaris: common inflammation of the pilosebaceous unit (sebaceous glands & hair follicles) Acne lesions Closed comedone (1-2 mm): whiteheads o First clinical
More informationOral Azithromycin Pulse Therapy and Daily Topical Benzoyl Peroxide in the Treatment of Acne Vulgaris: An Open Clinical Trial Study
Journal of Bangladesh College of Physicians and Surgeons Vol. 36, No. 1, January 218 Oral Azithromycin Pulse Therapy and Daily Topical Benzoyl Peroxide in the Treatment of Acne Vulgaris: An Open Clinical
More informationTreatment of adult female acne: a new challenge
DOI: 10.1111/jdv.13188 JEADV REVIEW ARTICLE Treatment of adult female acne: a new challenge B. Dreno* Department of Dermato-Cancerology, University of Nantes, Nantes, France *Correspondence: B. Dreno.
More informationAdvances in Acne Vulgaris Treatment
Insert to July 2017 Sponsored by Galderma Laboratories, L.P. Advances in Acne Vulgaris Treatment Strategies predicated on targeting multiple pathogenic features of acne especially inflammation are in the
More informationPROCEEDINGS PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP
PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP A HEALTHY 4-WEEK-OLD INFANT WITH ACNE A 4-week-old infant was brought to the pediatrician s office by his parents following the appearance
More informationOral Antibacterial Therapy for Acne Vulgaris: An Evidence- Based Review
Am J Clin Dermatol DOI 10.1007/s40257-017-0267-z EVIDENCE-BASED REVIEW Oral Antibacterial Therapy for Acne Vulgaris: An Evidence- Based Review Amanda Bienenfeld 1 Arielle R. Nagler 2 Seth J. Orlow 2 Springer
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationFrom new findings in acne pathogenesis to new approaches in treatment
DOI: 10.1111/jdv.13186 JEADV REVIEW ARTICLE From new findings in acne pathogenesis to new approaches in treatment H. P. M. Gollnick* Department of Dermatology & Venereology, Otto-von-Guericke University
More informationACNE VULGARIS IS AN EXCEPtionally
STUDY,.%, as Maintenance Therapy for Acne Vulgaris A Randomized, Controlled, Investigator-Blind Follow-up of a Recent Combination Study Diane M. Thiboutot, MD; Alan R. Shalita, MD; Paul S. Yamauchi, MD,
More informationClinical Study Synopsis for Public Disclosure
Clinical Study Synopsis for Public Disclosure These results are supplied for informational purposes only in the interest of scientific disclosure. The synopsis may include approved and non-approved uses,
More information30-Aug-17 ACNE IN THE POST ADOLESCENT FEMALE DR J VON NIDA ROYAL STREET DERMATOLOGY SIR CHARLES GAIRDNER HOSPITAL DISCLAIMER ACNE
DISCLAIMER ACNE IN THE POST ADOLESCENT FEMALE DR J VON NIDA ROYAL STREET DERMATOLOGY SIR CHARLES GAIRDNER HOSPITAL No conflicts of interest ACNE Multifactorial Disorder of the Pilosebaceous Unit Clinically
More informationRegulatory Status FDA approved indication: Tretinoin products are indicated for the topical treatment of acne vulgaris (5-16).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.03 Subject: Tretinoin Page: 1 of 5 Last Review Date: September 15, 2017 Tretinoin Description Atralin
More informationDuring the last 20 years, the number of topical
THERAPEUTICS FOR THE CLINICIAN Cumulative Irritation Potential of Adapalene 0.1% Cream and Gel Compared With Tretinoin Microsphere 0.04% and 0.1% Jonathan S. Dosik, MD; Kenneth Homer, MS; Stéphanie Arsonnaud
More informationEvidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada. Catherine Zip Nov 10, 2016
Evidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada Catherine Zip Nov 10, 2016 Acne Acne Classification Type Comedonal Mild-to-moderate papulopustular acne Severe Description
More informationEfficacy of Dapsone 5% gel in treatment of Acne vulgaris
International Journal of Research in Dermatology Jawade SA et al. Int J Res Dermatol. 2016 Dec;2(4):77-81 http://www.ijord.com Original Research Article DOI: http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20163502
More informationAcne vulgaris is one of the most common conditions
[LITERATURE REVIEW] A Review of Acne in Ethnic Skin Pathogenesis, Clinical Manifestations, and Management Strategies a ERICA C. DAVIS, MD; a,b VALERIE D. CALLENDER, MD a Callender Skin & Laser Center,
More informationOral Azithromycin Pulse Therapy and Daily Topical Adapalene in the Treatment of Acne Vulgaris: An Open Randomized Noncomparative Study
Original Article Oral Azithromycin Pulse Therapy and Daily Topical Adapalene in the Treatment of Acne Vulgaris: An Open Randomized Noncomparative Study Chowdhury MAH 1, Mamun SA 2, Uddin MJ 3, Khan RM
More informationACNE. What are the aims of this leaflet?
ACNE What are the aims of this leaflet? This leaflet has been written to help you understand more about acne - what it is, what causes it, what can be done about it and where you can find out more about
More informationManagement strategies for acne vulgaris
Clinical, Cosmetic and Investigational Dermatology open access to scientific and medical research Open Access Full Text Article Management strategies for acne vulgaris Evidence 2 Practice Kristen M Whitney
More informationInt. J. Pharm. Sci. Rev. Res., 29(1), November December 2014; Article No. 34, Pages:
Research Article A Comparative Study to Evaluate the Efficacy and Safety of Topical Isotretinoin and Versus Adapalene and in The Treatment of Grade I II Acne Vulgaris of Face Dr. Jyotirmoy Adhikary* 1,
More informationResearch Article. Formulation and evaluation of topical azelaic acid gel
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2015, 7(10):616-620 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Formulation and evaluation of topical azelaic acid
More informationTopical azelaic acid and the treatment ofacne: a clinical and laboratory comparison with oral tetraeycline
British Journal of Dermatology (1986) 114, 493-499- Topical azelaic acid and the treatment ofacne: a clinical and laboratory comparison with oral tetraeycline P.T.BLADON, B.M.BURKE, W.J.CUNLIFFE, R.A.FORSTER,
More informationClearSkin. Er:Glass 1540nm Laser Module. Orly Baror Gal, Eng.BioMedical. Clinical Applications Specialist
ClearSkin Er:Glass 1540nm Laser Module Orly Baror Gal, Eng.BioMedical Clinical Applications Specialist Acne - Introduction 2 Acne Vulgaris Very common Affects 80% of the population Almost every person
More informationEducation. Acne (acne vulgaris) is a. Putting out the spot fires. ClinicalReview AUTHOR. Learning objectives
ClinicalReview Learning objectives Understand the physiological determinants of acne development Understand the topical and systemic treatment of acne Understand the non-pharmacological treatment of acne
More informationKeratolytic Treatment
Keratolytic Treatment Ali Alikhan and Howard I. Maibach 54 Contents 54.1 Introduction... 397 54.2 Benzoyl Peroxide... 399 54.3 Retinoids: Tretinoin, Tazarotene, Adapalene... 400 54.4 Tretinoin... 401 54.5
More informationRelevant Disclosures. Investigator/Consultant-Allergan. Investigator-Galderma
Rosacea Update 2018 Lawrence J Green, MD Associate Clinical Professor Department of Dermatology George Washington University School of Medicne Washington DC Relevant Disclosures Investigator/Consultant-Allergan
More informationNew Medicines Committee Briefing March 2016 Review of preparations for treatment of acne
New Medicines Committee Briefing March 2016 Review of preparations for treatment of acne Summary: NICE CKS recommends topical retinoids (e.g. Adapalene (Differin ), adapalene combined with benzoyl peroxide
More informationAcne vulgaris is a common skin disease presenting
Efficacy and Safety of Dapsone Gel 5% for the Treatment of Acne Vulgaris in Adolescents Sharon Raimer, MD; J. Michael Maloney, MD; Marc Bourcier, MD; David Wilson, MD; Kim Papp, MD; Elaine Siegfried, MD;
More informationDoxycycline/Minocycline Step Therapy Criteria Program Summary
This criteria applies to Commercial, NetResults F series and Health Insurance Marketplace formularies. OBJECTIVE The intent of the Doxycycline/Minocycline Step Therapy (ST) program is to encourage the
More informationPresented by: Adelaide A Hebert, MD UTHealth McGovern Medical School, Houston, TX
Evaluation of the Efficacy, Safety and Tolerability of 4% Once-Daily in Subjects with Moderate to Severe Acne Vulgaris Treated Topically for Up to 52 Weeks A Hebert, J Del Rosso, M Rico, R Woolson, E de
More informationAcne. S Afr Fam Pract REVIEW. Abstract. Introduction. Pathogenesis. Lynn Lambert a* Amayeza Info Centre *
South African Family Practice 2015; 57(6):16-20 Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0] http://creativecommons.org/licenses/by-nc-nd/4.0 S Afr
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abnormal wound healing Acne and cybereducation, 131 and Google, 129 131 and online dangers, 131, 132 reliable online resources on, 130 self-proclaimed
More informationAcne Workshop Pediatric Acne: What s Erupting? AZAAP. Marcia Hogeling, MD, FAAD, FAAP
Acne Workshop Pediatric Acne: What s Erupting? AZAAP Marcia Hogeling, MD, FAAD, FAAP Disclosures Advisory Board Leo Pharma & Anacor Off label use of acne medicines Objectives Diagnose comedonal, inflammatory
More informationCUTIS. Although recommendations on the management. Do Not Copy
Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 5: A Guide on the Management of Rosacea James Q. Del Rosso, DO; Diane Thiboutot, MD; Richard Gallo,
More informationManagement of Acne in Primary Health Care: The good, the bad and the ugly
Management of Acne in Primary Health Care: The good, the bad and the ugly Marie-Lyne Bournival BSc, PG Dip (Health Sc), MN Nurse Practitioner Hei Hei Health Centre Christchurch, New Zealand Wednesday 29
More informationNew and Emerging Therapies for Acne and Rosacea. Diane S. Berson, M.D. Weill Cornell Medical College New York, New York
New and Emerging Therapies for Acne and Rosacea Diane S. Berson, M.D. Weill Cornell Medical College New York, New York Disclosures Allergan Galderma Ortho Derm Almirall Ferndale J & J Aclaris P & G Dermira
More informationWorld Journal of Pharmaceutical Research
Shraddhamayananda SJIF Impact Factor 5.045 Volume 3, Issue 6, 618-625. Research Article ISSN 2277 7105 EFFICACY OF HOMEOPATHIC MEDICINES IN THE TREATMENT OF ACNE *Swami Shraddhamayananda Ramakrishna Mission
More informationInteresting Cases in Dermatology: Clinical Pearls for Primary Care Providers
Interesting Cases in Dermatology: Clinical Pearls for Primary Care Providers 26 th Annual Southwestern Conference on Medicine Tucson, Arizona Friday, April 28 th, 2017 Shannon C. Trotter DO, FAOCD, FAAD
More informationAlgorithm for acne treatment: Ibero-Latin American consensus*
Special 689 Algorithm for acne treatment: Ibero-Latin American consensus* Ediléia Bagatin 1 Mercedes Florez-White 2 María Isabel Arias-Gomez 3 Ana Kaminsky 4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20177003
More informationAcne vulgaris has a substantial impact on a patient s
CMAJ Management of acne John Kraft MD, Anatoli Freiman MD DOI:10.1503/cmaj.090374 Acne vulgaris has a substantial impact on a patient s quality of life, affecting both self-esteem and psychosocial development.
More informationReports on Scientific Meetings
Hong Kong J. Dermatol. Venereol. (2007) 15, 34-41 CUHK Dermatology Symposium 2006 Reported by NPY Chan and FC Ip Date: 29 October, 2006 Venue: Postgraduate Education Centre, Prince of Wales Hospital, Shatin
More informationModerate Acne Vulgaris: Efficacy, Tolerance and Compliance of Oral Azithromycin Thrice Weekly for 12 Weeks
2008;16(1):13-18 CLINICAL ARTICLE Moderate Acne Vulgaris: Efficacy, Tolerance and Compliance of Oral Azithromycin Thrice Weekly for 12 Weeks Daniele Innocenzi, Nevena Skroza, Arianna Ruggiero, Maria Concetta
More informationX-Plain Acne Reference Summary
X-Plain Acne Reference Summary Nearly 17 million people in the United States have acne, making it one of the most common skin diseases in the USA. Although acne is not a serious health threat, severe acne
More informationRosacea Rosacea: how I hates ya! Richard Castillo, OD, DO The Oklahoma College of Optometry Northeastern State University Tahlequah, OK
Rosacea Rosacea: how I hates ya! Richard Castillo, OD, DO The Oklahoma College of Optometry Northeastern State University Tahlequah, OK Introduction Clinical Features Flushing Telangiectasia Erythema Papules
More informationTazorac (tazarotene), Fabior (tazarotene), tazarotene powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.02 Subject: Tazarotene Page: 1 of 5 Last Review Date: September 15, 2017 Tazarotene Description Tazorac
More informationA PROSPECTIVE OUTPATIENT CASE CONTROL STUDY OF SERUM LIPID PROFILE IN ACNE VULGARIS PATIENTS- AN ORIGINAL RESEARCH ARTICLE
A PROSPECTIVE OUTPATIENT CASE CONTROL STUDY OF SERUM LIPID PROFILE IN ACNE VULGARIS PATIENTS- AN ORIGINAL RESEARCH ARTICLE 1 Usha Kataria, 2 Yashdeep Malik, 3 Dinesh Chhillar, 4 Divya 1 Associate Professor,
More informationDoxycycline/Minocycline Step Therapy Criteria Program Summary
Doxycycline/Minocycline Step Therapy Criteria Program Summary Step therapy applies to Commercial and Health Insurance Marketplace formularies only. OBJECTIVE The intent of the Doxycycline/Minocycline Step
More informationOverall Goal: Identify key adolescent health issues and become comfortable interviewing an adolescent.
NCC Pediatrics Continuity Clinic Curriculum: Adolescent III Overall Goal: Identify key adolescent health issues and become comfortable interviewing an adolescent. Overall Outline: Adolescent I: Contraception
More informationA New Paradigm Shift in the Management of Atopic Dermatitis
Pharmacist Edition V o l u m e 6 N u m b e r 1 M a y - J u n e 2 0 1 1 C l i n i c a l E v i d e n c e. P r a c t i c a l A d v i c e Editor-in-Chief: Dr. Stuart Maddin Dr. Stuart Maddin, MD, FRCPC EDITOR-IN-CHIEF
More informationAcne Vulgaris: Guidelines to Clinical Practice. Jasen Knudsen, PharmD Clinical Pharmacy Services Kaiser Permanente NW
Acne Vulgaris: Guidelines to Clinical Practice Jasen Knudsen, PharmD Clinical Pharmacy Services Kaiser Permanente NW Objectives Be able to describe the epidemiologic presentation of acne vulgaris Be able
More informationPatients who suffer from mild-to-moderate acne are
[ORIGINAL RESEARCH] Self-diagnosis of Mild-to-Moderate Acne for Self Treatment with Blue Light Therapy a MICHAEL H. GOLD, MD; b ANNEKE ANDRIESSEN; a JULIE BIRON a Tennessee Clinical Research Center, Nashville,
More informationISPUB.COM. F Iraji, A Momeni, S Naji, A Siadat BACKGROUND
ISPUB.COM The Internet Journal of Dermatology Volume 3 Number 2 The Efficacy Of Topical Cyproterone Acetate Alcohol Lotion Versus Placebo In The Treatment Of The Mild To Moderate Acne Vulgaris: A Double
More informationDr Amarjeet Singh, Resident, Department of Dermatology, Venereology and Leprosy, National Institute of Medical Sciences, Jaipur, Rajasthan, INDIA.
Research Article Efficacy of isotretinoin alone and its combination with azithromycin in moderate to severe acne vulgaris: a comparative study Kishor Singh 1, Amarjeet Singh 2*, Sanjay Kanodia 3, Jyoti
More informationCLINICAL TRIAL. Michael Vince D. Busa, MD, DPDS a, Janice Natasha C. Ng, MD, DPDS a, Maricarr Pamela M. Lacuesta-Gutierrez, MD, FPDS a
CLINICAL TRIAL A Prospective, Randomized, Double-Blind, Comparative Study on the Efficacy and Safety of 2% Enzymatic Virgin Coconut Oil Monoglyceride Cream versus 5% Benzoyl Peroxide Cream in the Treatment
More informationOral Isotretinoin: An Analysis of Its Utilization in a Managed Care Organization
ORIGINAL RESEARCH Oral Isotretinoin: An Analysis of Its Utilization in a Managed Care Organization KRISTINA CHEN, PharmD, MS; T. JEFFREY WHITE, PharmD, MS; MICHAEL JUZBA, PharmD, MBA, MS; and EUNICE CHANG,
More informationEficacy of trichloroacetic acid peel versus 15% topical azelaic acid gel in the treatment of acne vulgaris a comparative study
Acta Medica Marisiensis 2015;61(1):25-30 DOI: 10.1515/amma-2015-0014 RESEARCH ARTICLE Eficacy of trichloroacetic acid peel versus 15% topical azelaic acid gel in the of acne vulgaris a comparative study
More informationAcne vulgaris, or common acne, is an
...CONTINUING MEDICAL EDUCATION... CME ARTICLE Acne Vulgaris: Pathogenesis and Therapeutic Approach Daniel G. Federman, MD; and Robert S. Kirsner, MD AUDIENCE This activity is designed for primary care
More informationEuropean evidence-based (S3) guideline for the treatment of acne update 2016 short version
DOI: 10.1111/jdv.13776 JEADV ORIGINAL ARTICLE European evidence-based (S3) guideline f the treatment of acne update 2016 sht version A. Nast, 1, *B.Dreno, 2 V. Bettoli, 3 Z. Bukvic Mokos, 4 K. Degitz,
More informationDOI /j x
THERAPEUTICS DOI 1.1111/j.1365-2133.27.883.x Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris A. Charakida,
More informationMıCELLES AS NANOSıZED CARRıERS FOR SKıN DELıVERY OF DRUGS. Sevgi Güngör
MıCELLES AS NANOSıZED CARRıERS FOR SKıN DELıVERY OF DRUGS Sevgi Güngör Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology 4 th International Conference on Nanotek&Expo,01-03
More informationWith the continuing rise in clinical reports
With the continuing rise in clinical reports of cutaneous MRSA (Methicillin-resistant Staphylococcus aureus) infections in the community and public health officials issuing consistent warnings about the
More informationADULT FEMALE ACNE IS NOT TEENAGE ACNE
ABSTRACT BOOK Satellite Symposium EADV 2011 ADULT FEMALE ACNE IS NOT TEENAGE ACNE Chair: Professor Dr. Brigitte Dréno October 22 nd Room: Auditorium III F_Abstract Book Skinoren.indd 1 07/09/11 18:24 Program
More informationOriginal Research Article. Ishan Pandya 1, Purna Pandya 2 *, Neha Pethani 3, Rima Bharatbhai Shah 2
International Journal of Research in Dermatology Pandya I et al. Int J Res Dermatol. 2017 Jun;3(2):228-233 http://www.ijord.com Original Research Article DOI: http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20172202
More informationEvaluation of anti-acne property of purified bee venom serum in humans
Original Contribution Journal of Cosmetic Dermatology, 15, 324--329 Evaluation of anti-acne property of purified bee venom serum in humans Sang Mi Han, PhD, 1 Sok Cheon Pak, PhD, 2 Young Mee Nicholls,
More informationAcne is one of the most burdensome diseases
CME Guidelines CMAJ Management of acne: Canadian clinical practice guideline Yuka Asai MD MSc, Akerke Baibergenova MD PhD, Maha Dutil MD MEd, Shannon Humphrey BSc MD, Peter Hull MMed PhD, Charles Lynde
More informationSTUDY. Successful Treatment of Acne Vulgaris Using a New Method
STUDY Successful Treatment of Acne Vulgaris Using a New Method Results of a Randomized Vehicle-Controlled Trial of Short-Contact Therapy With 0.1% Tazarotene Gel Susan Bershad, MD; Giselle Kranjac Singer,
More informationActinic keratoses (AKs) and acne are common skin
CASE STUDIES PRACTICAL APPLICATIONS AND INSIGHTS JULIE C. HARPER, M.D. Actinic keratoses (AKs) and acne are common skin disorders in dermatology. The previous articles provided an overview of the pathogenesis
More informationDERMAZELAN ACNE PILOSEBACEOUS FOLLICLE DISFUNCTION
ACNE = PILOSEBACEOUS FOLLICLE DISFUNCTION PATHOGENESIS FUNCTIONAL DISFUNCTIONS OF THE SEBACEOUS GLANDS MULTIFACTORIAL ETHIOLOGY HYPERSEBORRHEA FOLICULAR HYPERKERATOSIS SAPROFITE MICROFLORA PROLIFERATION
More informationACNE THERAPY Experience with Palomar LuxV Intense Pulsed Light Therapy
ACNE THERAPY Experience with Palomar LuxV Intense Pulsed Light Therapy Robert S. Berger, MD, FAAD, FASDS., Assistant Professor, Department of Dermatology, The Johns Hopkins University, Baltimore, Private
More informationA Novel Approach for Acne Treatment
A Novel Approach for Acne Treatment E.V. Ross, M.D.; M.A. Blair, M.D.; B.S. Graham, M.D.; Naval Medical Center, San Diego, CA D.Y. Paithankar, Ph.D.; B.A. Saleh, M.Eng.; Candela Corporation, Wayland, MA
More informationAcne. Questions Answers & about...
Questions Answers & about... Acne National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institutes of Health Public Health Service U.S. Department of Health and Human Services
More informationDermatology for the PCP
Dermatology for the PCP Laura S. Winterfield, MD MPH Associate Professor Medical University of South Carolina I have no relevant conflicts of interest. 1 Learning Objectives Identify common skin conditions
More informationEvidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne
SUPPLEMENT ARTICLE Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne AUTHORS: Lawrence F. Eichenfield, MD, a Andrew C. Krakowski, MD, a Caroline Piggott, MD, a James Del
More informationTazorac (tazarotene), Fabior (tazarotene), tazarotene powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.14.02 Subject: Tazarotene Page: 1 of 5 Last Review Date: June 12, 2014 Tazarotene Description Tazorac
More information